HedgePath Pharmaceuticals, Inc. announced that the company Board of Directors has elected W. Mark Watson, CPA as Chairman of the Board, effective April 15, 2019. As previously announced, E. Brendan Magrab, HedgePath's Chairman of the Board since December 2016, is stepping down from that position in order to fulfill his duties as Chief Executive Officer of Epalex Corporation. Mr. Magrab is expected to continue to serve on the HedgePath board until the earlier of July 1, 2019 or when a new board member is identified.